Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9) system has emerged in recent years as a highly efficient RNA-guided gene manipulation platform. Simultaneous editing or transcriptional activation/suppression of different genes becomes feasible with the co-delivery of multiple guide RNAs (gRNAs). Here, we report that multiple gRNAs linked with self-cleaving ribozymes and/or tRNA could be simultaneously expressed from a single U6 promoter to exert genome editing of dystrophin and myosin binding protein C3 in human and mouse cells. Moreover, this strategy allows the expression of multiple gRNAs for synergistic transcription activation of follistatin when used with catalytically inactive dCas9-VP64 or dCas9-p300core fusions. Finally, the gRNAs linked by the self-cleaving ribozymes and tRNA could be expressed from RNA polymerase type II (pol II) promoters such as generic CMV and muscle/heart-specific MHCK7. This is particularly useful for in vivo applications when the packaging capacity of recombinant adeno-associated virus is limited while tissue-specific delivery of gRNAs and Cas9 is desired. Taken together, this study provides a novel strategy to enable tissue-specific expression of more than one gRNAs for multiplex gene editing from a single pol II promoter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Relative tissue-specific expression of two gRNAs for CRISPR/Cas gene editing in myotubes was achieved by linking a muscle-specific MHCK7 promoter (pol II) with gRNA-linked self-cleaving ribozyme sequences derived of Hepatitis delta virus (HDV) and a Hammerhead (HH) sequence [134-137].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 1×
“The modified gene activation systems can robustly activate the gene expression with gRNA targeted to within 200 bp upstream of the transcription start site (13).”
BackgroundKruger, K., Grabowski, P. J., Zaug, A. J., Sands, J., Gottschling, D. E., & Cech, T. R. (1982) · Cell · doi:10.1016/0092-8674(82)90414-7 · Cited by 2,331
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G.-W., Park, J., Blackburn, E. H., Weissman, J. S., Qi, L. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.12.001 · Cited by 1,963
Hilton, I. B., D'Ippolito, A. M., Vockley, C. M., Thakore, P. I., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3199 · Cited by 1,885
Targeted genome modification of crop plants using a CRISPR-Cas system
Shan, Q., Wang, Y., Li, J., Zhang, Y., Chen, K., Liang, Z., Zhang, K., Liu, J., Xi, J. J., Qiu, J.-L., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2650 · Cited by 1,810
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system
Xie, K., Minkenberg, B., & Yang, Y. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420294112 · Cited by 1,552
Li, J.-F., Norville, J. E., Aach, J., McCormack, M., Zhang, D., Bush, J., Church, G. M., & Sheen, J. (2013) · Nature Biotechnology · doi:10.1038/nbt.2654 · Cited by 1,510
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
Perez-Pinera, P., Kocak, D. D., Vockley, C. M., Adler, A. F., Kabadi, A. M., Polstein, L. R., Thakore, P. I., Glass, K. A., Ousterout, D. G., Leong, K. W., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2600 · Cited by 1,328
CRISPR RNA–guided activation of endogenous human genes
Maeder, M. L., Linder, S. J., Cascio, V. M., Fu, Y., Ho, Q. H., & Joung, J. K. (2013) · Nature Methods · doi:10.1038/nmeth.2598 · Cited by 1,249
CRISPR interference (CRISPRi) for sequence-specific control of gene expression
Larson, M. H., Gilbert, L. A., Wang, X., Lim, W. A., Weissman, J. S., & Qi, L. S. (2013) · Nature Protocols · doi:10.1038/nprot.2013.132 · Cited by 1,212
Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt520 · Cited by 1,145
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Nelson, C. E., Hakim, C. H., Ousterout, D. G., Thakore, P. I., Moreb, E. A., Rivera, R. M. C., Madhavan, S., Pan, X., Ran, F. A., Yan, W. X., et al. (2016) · Science · doi:10.1126/science.aad5143 · Cited by 1,144
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Tabebordbar, M., Zhu, K., Cheng, J. K. W., Chew, W. L., Widrick, J. J., Yan, W. X., Maesner, C., Wu, E. Y., Xiao, R., Ran, F. A., et al. (2016) · Science · doi:10.1126/science.aad5177 · Cited by 1,046
Eagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00140-2 · Cited by 1,009
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon, D., Goodwin, M. J., Aryee, M. J., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2908 · Cited by 952
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Yin, H., Xue, W., Chen, S., Bogorad, R. L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P. A., Jacks, T., & Anderson, D. G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2884 · Cited by 951
Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds
Zalatan, J. G., Lee, M. E., Almeida, R., Gilbert, L. A., Whitehead, E. H., La Russa, M., Tsai, J. C., Weissman, J. S., Dueber, J. E., Qi, L. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.052 · Cited by 938
Long, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Optical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2013) · Nature · doi:10.1038/nature12466 · Cited by 803
Cheng, A. W., Wang, H., Yang, H., Shi, L., Katz, Y., Theunissen, T. W., Rangarajan, S., Shivalila, C. S., Dadon, D. B., & Jaenisch, R. (2013) · Cell Research · doi:10.1038/cr.2013.122 · Cited by 751
The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy
Nigro, G., Comi, L. I., Politano, L., & Bain, R. J. I. (1990) · International Journal of Cardiology · doi:10.1016/0167-5273(90)90082-g · Cited by 731
Large chromosomal deletions and heritable small genetic changes induced by CRISPR/Cas9 in rice
Zhou, H., Liu, B., Weeks, D. P., Spalding, M. H., & Yang, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku806 · Cited by 598
Gao, Y., & Zhao, Y. (2014) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12152 · Cited by 562
Self-citationThe expanding RNA polymerase III transcriptome
Dieci, G., Fiorino, G., Castelnuovo, M., Teichmann, M., & Pagano, A. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.09.001 · Cited by 534
SURVEY AND SUMMARY Transcription by RNA polymerases I and III
Paule, M. R. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1283 · Cited by 502
Nissim, L., Perli, S. D., Fridkin, A., Perez-Pinera, P., & Lu, T. K. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.022 · Cited by 438
Augmenting CRISPR applications in Drosophila with tRNA-flanked sgRNAs
Port, F., & Bullock, S. L. (2016) · Nature Methods · doi:10.1038/nmeth.3972 · Cited by 437
Capturing the Structure of a Catalytic RNA Intermediate: The Hammerhead Ribozyme
Scott, W. G., Murray, J. B., Arnold, J. R. P., Stoddard, B. L., & Klug, A. (1996) · Science · doi:10.1126/science.274.5295.2065 · Cited by 407
General Acid-Base Catalysis in the Mechanism of a Hepatitis Delta Virus Ribozyme
Nakano, S.-I., Chadalavada, D. M., & Bevilacqua, P. C. (2000) · Science · doi:10.1126/science.287.5457.1493 · Cited by 385
Young, C. S., Hicks, M. R., Ermolova, N. V., Nakano, H., Jan, M., Younesi, S., Karumbayaram, S., Kumagai-Cresse, C., Wang, D., Zack, J. A., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.021 · Cited by 383
Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency
Dang, Y., Jia, G., Choi, J., Ma, H., Anaya, E., Ye, C., Shankar, P., & Wu, H. (2015) · Genome Biology · doi:10.1186/s13059-015-0846-3 · Cited by 364
Carrier, L., Bonne, G., Bahrend, E., Yu, B., Richard, P., Niel, F., Hainque, B., Cruaud, C., Gary, F., Labeit, S., et al. (1997) · Circulation Research · doi:10.1161/01.res.0000435859.24609.b3 · Cited by 302
Transcription by RNA polymerase III: more complex than we thought
White, R. J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3001 · Cited by 248
CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
Xu, L., Park, K. H., Zhao, L., Xu, J., El Refaey, M., Gao, Y., Zhu, H., Ma, J., & Han, R. (2016) · Molecular Therapy · doi:10.1038/mt.2015.192 · Cited by 244
Self-citationSalva, M. Z., Himeda, C. L., Tai, P. W., Nishiuchi, E., Gregorevic, P., Allen, J. M., Finn, E. E., Nguyen, Q. G., Blankinship, M. J., Meuse, L., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300027 · Cited by 232 · cited 3×
“Salva et al. demonstrated that the MHCK7 promoter had ∼400-, ∼50- and ∼10-fold higher activity in cardiac, diaphragm, and soleus muscles, respectively when compared to their previous ‘best’ construct creatine kinase 6 (CK6) (57).”
BackgroundResultInfluentialQi, W., Zhu, T., Tian, Z., Li, C., Zhang, W., & Song, R. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0289-2 · Cited by 207
CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
Zhang, W.-W., & Matlashewski, G. (2015) · mBio · doi:10.1128/mbio.00861-15 · Cited by 195
Chen, B., Hu, J., Almeida, R., Liu, H., Balakrishnan, S., Covill-Cooke, C., Lim, W. A., & Huang, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1533 · Cited by 186
Mechanism of Eukaryotic RNA Polymerase III Transcription Termination
Nielsen, S., Yuzenkova, Y., & Zenkin, N. (2013) · Science · doi:10.1126/science.1237934 · Cited by 146
Lee, C. M., Cradick, T. J., Fine, E. J., & Bao, G. (2016) · Molecular Therapy · doi:10.1038/mt.2016.1 · Cited by 134
Iyombe-Engembe, J.-P., Ouellet, D. L., Barbeau, X., Rousseau, J., Chapdelaine, P., Lagüe, P., & Tremblay, J. P. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.58 · Cited by 92
tRNA acceptor stem and anticodon bases form independent codes related to protein folding
Carter, C. W., & Wolfenden, R. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507569112 · Cited by 79
Sweeney, J. A., & Hennessey, J. P. (2002) · Virology · doi:10.1006/viro.2002.1406 · Cited by 77
Expression of CRISPR/Cas single guide RNAs using small tRNA promoters
Mefferd, A. L., Kornepati, A. V. R., Bogerd, H. P., Kennedy, E. M., & Cullen, B. R. (2015) · RNA · doi:10.1261/rna.051631.115 · Cited by 75
Development of a mono-promoter-driven CRISPR/Cas9 system in mammalian cells
Yoshioka, S., Fujii, W., Ogawa, T., Sugiura, K., & Naito, K. (2015) · Scientific Reports · doi:10.1038/srep18341 · Cited by 70
Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy
Xu, J., Refaey, M. E., Xu, L. M., Zhao, L., Gao, Y., Floyd, K. T., Karaze, T., Janssen, P. M. L., & Han, R. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0069-z · Cited by 53
Self-citationXu, L. M., Zhao, P., Mariano, A. T., & Han, R. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.39 · Cited by 41
Self-citationRNA-polymerase III-driven expression cassettes in human gene therapy.
Medina, M. F. C., & Joshi, S. (1999) · PubMed · Cited by 24
Expansion of the CRISPR toolbox in an animal with tRNA-flanked Cas9 and Cpf1 gRNAsPreprint
Port, F., & Bullock, S. L. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/046417 · Cited by 10
Research works printed but not linked: 1
- 10.1161/01.RES.80.3.427 · doi:10.1161/01.res.80.3.427
Cited by
Multiplexed CRISPR technologies for gene editing and transcriptional regulation
McCarty, N. S., Graham, A. E., Studená, L., & Ledesma-Amaro, R. (2020) · Nature Communications · doi:10.1038/s41467-020-15053-x · Cited by 552
Cas9 versus Cas12a/Cpf1: Structure–function comparisons and implications for genome editing
Swarts, D. C., & Jinek, M. (2018) · WIREs RNA · doi:10.1002/wrna.1481 · Cited by 267
Prediction of the sequence-specific cleavage activity of Cas9 variants
Kim, N., Kim, H. K., Lee, S., Seo, J. H., Choi, J. W., Park, J., Min, S., Yoon, S., Cho, S.-R., & Kim, H. H. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0537-9 · Cited by 198
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
Direct-seq: programmed gRNA scaffold for streamlined scRNA-seq in CRISPR screen
Song, Q., Ni, K., Liu, M., Li, Y., Wang, L., Wang, Y., Liu, Y., Yu, Z., Qi, Y., Lu, Z., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-02044-w · Cited by 26
Metadata
- Authors
- Xu, L., Zhao, L., Gao, Y., Xu, J., & Han, R.
- Affiliations
- The Ohio State University Wexner Medical Center (US)
- Corresponding author
- Han, Renzhi
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-10-30
- Volume
- 45
- Issue
- 5
- Pages
- gkw1048
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC5389707
- OpenAlex
- W2546112219
- Cited by
- 91
- References
- 59
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 8 · 2023: 5 · 2022: 14 · 2021: 5 · 2020: 20 · 2019: 8 · 2018: 11 · 2017: 9
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL116546)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR064241)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- multiplex genome editing, CRISPR/Cas9, self-cleaving ribozymes, tRNA, U6 promoter, RNA polymerase II promoter, tissue-specific gene delivery, dystrophin, follistatin, transcriptional activation, muscle-specific promoter
- MeSH terms
- Gene Editing, RNA, Guide, CRISPR-Cas Systems, Animals, Cell Line, Cytomegalovirus, DNA Polymerase II, Humans, Liver, Macrophages, Mice, Inbred C57BL, Mice, Transgenic, Myosins, Promoter Regions, Genetic, Recombinant Fusion Proteins, RNA, Small Nuclear, RNA, Transfer, Transcriptional Activation, Dystrophin, RNA, Catalytic, Muscle, Skeletal, Myoblasts, Follistatin, Mice, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.